- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Recombinant CHGA antibody recognizes Chromogranin A, a secretory granule protein encoded by the CHGA gene and a well-established marker of neuroendocrine differentiation. Recombinant CHGA Antibody (clone rCHGA/777) is a mouse monoclonal antibody generated through recombinant expression to provide consistent performance and lot-to-lot reproducibility. Chromogranin A localizes to the cytoplasm within dense-core secretory vesicles of endocrine and neuroendocrine cells, where it participates in hormone packaging, granule biogenesis, and regulated secretion.
CHGA antibody, also referred to as Chromogranin A antibody, CgA antibody, and CGA antibody in the literature, targets a member of the granin family of acidic secretory proteins. After synthesis, Chromogranin A undergoes proteolytic processing to generate multiple biologically active peptides, including vasostatin, pancreastatin, and catestatin. These peptides are involved in modulation of cardiovascular function, metabolic regulation, and neuroendocrine signaling pathways. Within the trans-Golgi network, Chromogranin A promotes aggregation of peptide hormones and contributes structurally to formation and stabilization of secretory granules.
CHGA expression is characteristic of adrenal medulla chromaffin cells, pancreatic islet cells, gastrointestinal enteroendocrine cells, parathyroid tissue, and other dispersed neuroendocrine cell populations. The expected immunohistochemical pattern is cytoplasmic granular staining reflecting localization within secretory vesicles. Because of this lineage-restricted distribution, Chromogranin A serves as a robust research marker for identifying neuroendocrine cells and studying differentiation pathways.
In oncology research, Chromogranin A expression is frequently evaluated in neuroendocrine neoplasms including carcinoid tumors, pancreatic neuroendocrine tumors, small cell carcinoma, medullary thyroid carcinoma, and pheochromocytoma. Strong cytoplasmic staining supports neuroendocrine lineage, whereas most non-neuroendocrine carcinomas demonstrate limited or absent expression. Recombinant CHGA Antibody (clone rCHGA/777) enables reliable detection of Chromogranin A expression patterns in normal and neoplastic tissues for research use at NSJ Bioreagents.
Optimal dilution of the recombinant CHGA antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant human protein was used as the immunogen for the recombinant CHGA antibody.
Store the recombinant CHGA antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.